» Articles » PMID: 15210774

Distinct Maturation Of, but Not Migration Between, Human Monocyte-derived Dendritic Cells Upon Ingestion of Apoptotic Cells of Early or Late Phases

Overview
Journal J Immunol
Date 2004 Jun 24
PMID 15210774
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Cell death via apoptosis is a normal physiological process. Rapid, but silent, removal of apoptotic cells (ACs) plays an essential role in maintaining homeostasis in the immune system. Defective clearance of ACs allows ACs to accumulate and undergo late phase apoptosis, also known as secondary necrosis, which may generate danger signals, leading to inflammation or autoimmunity. In this study we investigate the outcome of dendritic cells (DCs), which are potent APCs, on the interaction with ACs of early or late phase. Immature DCs internalized ACs of both early and late phases with similar efficiency. However, DCs that had taken up ACs of early phase acquired a non-fully mature DC phenotype, expressing low MHC class II complex, costimulatory molecule CD40, and mature DC-restricted marker CD83, and had a low capacity to stimulate allogeneic CD4+ T cell proliferation, whereas DCs that had taken up ACs of late phase acquired a mature DC phenotype with enhanced T cell stimulatory capacity. Ingestion of either early or late ACs induced minimal production of IL-12 and modulated CC chemokine and CCR expression in DCs. In particular, there was down-regulation of CCR5 and up-regulation of CCR7, resulting in switches in responsiveness from inflammatory to lymphoid chemokines. We conclude from these data that after taking up ACs of either early or late phases, DCs acquire the capability of homing to draining lymph nodes, and the distinct maturation between DCs taking up early or late ACs may contribute to DC function in the induction of T cell tolerance or Ag-specific T cell response, respectively.

Citing Articles

Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights.

Hoseinzadeh A, Esmaeili S, Sahebi R, Melak A, Mahmoudi M, Hasannia M Stem Cell Res Ther. 2025; 16(1):33.

PMID: 39901306 PMC: 11792531. DOI: 10.1186/s13287-025-04158-z.


Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases.

Benne N, Ter Braake D, Stoppelenburg A, Broere F Front Immunol. 2022; 13:864403.

PMID: 35392079 PMC: 8981588. DOI: 10.3389/fimmu.2022.864403.


Dendritic cells that phagocytose apoptotic macrophages loaded with mycobacterial antigens activate CD8 T cells via cross-presentation.

Espinosa-Cueto P, Magallanes-Puebla A, Castellanos C, Mancilla R PLoS One. 2017; 12(8):e0182126.

PMID: 28767693 PMC: 5540487. DOI: 10.1371/journal.pone.0182126.


Innate and humoral recognition of the products of cell death: differential antigenicity and immunogenicity in lupus.

Arora P, Malik M, Sachdeva R, Saxena L, Das J, Ramachandran V Clin Exp Immunol. 2016; 187(3):353-368.

PMID: 27783388 PMC: 5290248. DOI: 10.1111/cei.12889.


Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease.

Morelli A, Larregina A Stem Cells. 2016; 34(5):1142-50.

PMID: 26865545 PMC: 4860051. DOI: 10.1002/stem.2326.